Cerevel Therapeutics Inc...

NASDAQ: CERE · Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM

Cerevel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
320.44M 990.97M 155.72M 175.76M 153.82M 136.52M 248.6M 138.22M 91.76M 193.02M 669.68M 327.06M 343.29M
Short-Term Investments
525.86M 574.5M 521.16M 560.66M 673.17M 755.51M 741.32M 392.99M 451.18M 372.67M n/a n/a n/a
Long-Term Investments
218.59M 187.16M 81.34M 88.64M 36.05M 58.13M 39.86M 1.87M 7.93M 52.27M 4.2M 4.2M 4.2M
Other Long-Term Assets
4.58M 3.43M 5.64M 5.78M 5.08M 4.76M 4.66M 2.76M 4.41M 6.93M 2.27M 3.1M 2.31M
Receivables
4.96M 5.29M 3.41M 4.13M 3.2M n/a 824K 981K 602K 729K n/a n/a n/a
Inventory
8.24M n/a -3.41M -4.13M -3.2M -2.05M 7.58M 6.85M 9.71M -729K n/a n/a n/a
Other Current Assets
8.32M 10.68M 7.5M 11.11M 10.59M 13.62M 7.92M 7.95M 10M 12.33M 5.35M 4.72M 6.52M
Total Current Assets
859.58M 1.01B 687.79M 751.67M 840.78M 905.65M 998.66M 540.14M 553.55M 578.02M 675.03M 331.78M 349.81M
Property-Plant & Equipment
44.6M 45.77M 47.19M 48.26M 48.44M 49.29M 50.53M 51.89M 52.66M 51.7M 51.98M 51.92M 51.78M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
267.77M 236.36M 134.18M 142.68M 89.56M 112.17M 95.05M 56.52M 65M 110.9M 58.45M 59.22M 58.29M
Total Assets
1.13B 1.24B 821.96M 894.35M 930.35M 1.02B 1.09B 596.66M 618.55M 688.92M 733.48M 391M 408.1M
Account Payables
10.84M 11.86M 11.54M 9.39M 7.32M 10.06M 14.97M 11.01M 8.18M 11.3M 5.45M 4.99M 7.75M
Deferred Revenue
-3.52M n/a n/a n/a n/a n/a n/a 42.17M n/a 28.43M 22.59M 21.7M 24.1M
Short-Term Debt
3.52M 3.4M 3.28M 3.15M 3.03M 2.9M 2.79M 2.67M 2.56M 2.44M 2.33M 2.24M 2.14M
Other Current Liabilities
69.75M 76.91M 64.02M 53.02M 52.61M 59.6M 42.26M 43.06M 24.57M 28.8M 23.02M 22.04M 24.26M
Total Current Liabilities
84.1M 92.18M 78.84M 65.56M 62.96M 72.56M 60.02M 56.74M 35.32M 42.54M 30.8M 29.26M 34.15M
Long-Term Debt
364.79M 365.21M 365.61M 365.98M 366.34M 366.67M 366.95M 32.69M 33.41M 34.11M 34.75M 32.91M 32.95M
Other Long-Term Liabilities
114M 112.16M 104.56M 112.31M 69.34M 57.35M 63.38M 54.41M 28.33M 33.54M 38.85M 34.95M 965K
Total Long-Term Liabilities
478.78M 477.37M 470.16M 478.29M 435.68M 424.02M 430.33M 87.1M 61.73M 67.65M 73.6M 67.86M 33.92M
Total Liabilities
562.89M 569.55M 549M 543.85M 498.64M 496.58M 490.35M 143.84M 97.05M 110.19M 104.4M 97.12M 68.07M
Total Debt
368.3M 480.78M 365.61M 365.98M 366.34M 366.67M 369.74M 35.36M 35.97M 36.55M 37.09M 35.14M 35.09M
Common Stock
18K 18K 16K 16K 16K 16K 16K 15K 15K 15K 15K 13K 13K
Retained Earnings
-1.53B -1.4B -1.27B -1.17B -1.07B -967.75M -874.95M -775.01M -684.54M -616.24M -557.19M -495.13M -441.89M
Comprehensive Income
-1.09M 1.77M 1.68M 1.14M 3.69M 3.1M 5.19M 7.99M -1.33M -986K -533K n/a 0.00
Shareholders Equity
564.46M 673.75M 272.96M 350.5M 431.71M 521.24M 603.36M 452.81M 521.5M 578.73M 629.08M 293.89M 340.04M
Total Investments
744.45M 187.16M 521.16M 560.66M 673.17M 813.63M 781.18M 392.99M 459.11M 424.94M 4.2M 4.2M 4.2M